My First Blog Post

New Blog Site for

Derek C Stewart!

Be yourself; Everyone else is already taken.

— Oscar Wilde.

This is the first post on my new blog. I’m just getting this new blog going, so stay tuned for more. Subscribe below to get notified when I post new updates.

First of all – I hope everyone is staying as safe as possible, keeping well and being as kind as we can be. I am taking the view that if I am to be isolated I might as well learn something new!

  1. Using WordPress as my blog site
  2. Learning Gaelic from Duolingo

Like everything new, it all feels a bit strange so I am just taking it step at a time.

Public Involvement with the Strategic aspects of Health Research – What is it all about?

As a ‘Strategic Partner and Advisor’, with the Health Research Board – Trials Methodology Research Network (HRB-TMRN), Ireland, it invites the question what does that role actually mean in general and for public involvement? 

These notes are an attempt to reflect on some of the whys and wherefores of offering strategic advice particularly around actively involving patients and the public with trials methodology research. It is intended as an exploratory starting point for discussion to help others who may play similar roles. It is an attempt to move beyond just reporting on the activities and actions on the past year. It is not a definitive answer. 

Strategic

By the term strategic, I am referring to public involvement in the oversight and governance of health research programmes and/ or policy initiatives – that high level or helicopter view. The terms, partner and advisor, referring to being external to the organisation. 

When the invitation arrives, it can be useful, as members of the public, to consider what experiences we bring together with our knowledge and skills. It is often beyond just our direct personal contacts with health. With these considerations it can also be helpful to list the key features and benefits of our strengths as well as what we don’t know. Equally, it is worth giving some thought to what we might gain from such involvement.

What does it involve?

I hope that my input is about being a critical friend able to help maintain people’s respect and trust whilst speaking up about the public’s needs. My distance from the day to day aspects of the organisation and my other experiences provide an external voice on proceedings. An informed reflective opinion.

Much of the time it is about listening for the items that have relevance to the public. I have noticed that a lot of times I am a conduit of information, helping make connections between people and initiatives – gathering knowledge and exchanging it where appropriate. One of the great advantages of public involvement is the range of activities and different researchers we meet. Hopefully it offers some assurance and a sufficient productive challenge with the formulation policies and strategies. 

From the patient perspective and for public involvement it is about the overall direction of travel – the what and why. It is whether what is taking place makes a difference, directly or indirectly, to the public experience of health and social care. Increasingly, this must include more people, increasing the diversity and addressing health inequalities. 

It involves us being present, contributing and adding value.

How should we advise?

My personal health experiences (throat cancer in 1995) opened the door into this world yet this has less direct relevance to trials methodology research. I am not telling my story. In this landscape it is more about what the research participants might experience either as a patient or member of the public. It many respects it is to help us all think about how we make better choices and decisions.

It is an amalgamation of my work as a teacher in behavioural management, other life experiences and being a patient that offers different contexts to compare and contrast the things being discussed.

It is about comparing and contrasting against those other experiences to provide ways of looking at problems, understanding certain situations and bringing the discussion together to help find suitable solutions. 

Sometimes it is about helping guide the moral ‘patients compass’ or asking if the Emperor has no clothes. It is taking account of the practical considerations to provide overall direction and assist the leadership on matters of substance to the public. 

It is about having an informed external view therefore using our time to reflect and learn.

Involvement with trials methodology research is more about ‘the public view’ of these studies, their opinions and how we might gain those insights. It is about advising on how to engage and include more people’s views. 

What is our purpose?

Our purpose, as public partners in these roles, is perhaps…

  • to be curious and ask the questions about what the discussion means for patient groups and communities,
  • to raise issues of importance to the public and for those who might choose to take part in research studies,
  • to help us ‘all’ think how to engage, involve and help people have a meaningful say,
  • to encourage and help in meetings and on visits with communities, patient groups and other advocates,
  • to help open the doors and windows of research for greater transparency, diversity and participation,
  • to consider what it might mean when the research findings get published and perhaps put into practice,
  • to gather and help tell the stories of people making an inclusive difference – i.e. making health research better

It seems therefore right and sensible to have us at the table to understand the issues from the public and/or patient perspectives, to hear our opinions and to be part of finding the solutions to enable health research to be genuinely inclusive. 

It is the consideration of the experience of study participants and patients in general that marks the difference between involvement with single clinical study which has a more personal connection and any strategic roles. 

Our contributions are part of a wider change around improving diversity, transparency, trust and inclusion as well as being the morally right thing to do. It is mutually an opportunity to learn about different aspects of research governance, culture, conduct and practice. 

In conclusion

As a patient advocate/public partner, we are there as the reminder to focus on things that make a real difference to people’s lives.

Involvement of public in governance roles, hopefully, adds value and helps create and illustrate partnership working. It may help with transparency, accountability, to maintain trust and to make better informed choices

The challenge for all of us is to ensure that we address health disparities and ensure that equality, diversity and inclusion (EDI)  https://ppinetwork.ie/our-work/equality-diversity-inclusion/ is central the work of trials methodology research

If the strategic involvement is about being on a Trials Management Group then this 10 min clip of me talking about it, might be of interest.: https://youtu.be/S1fnZby_6nY?si=-f4puzKRTcxuFf-c 

Public Involvement, Engagement with Non-Clinical Research.

This was written as an introduction to the consultation from the UKRI Medical Research Council about this very topic. You can also find out more here.

What people may need.

How can a member of the public, a patient, carer or relation find information about scientific discovery, hear about the latest breakthrough in health research; and/or offer opinion, insights, advice from their life experiences; and/or enquire about studies that are taking place in this area of health research?

Members of the public should not have to work out whether they are being actively involved or engaged or participatingin a study to find their way through the landscape of science innovation (most often referred to as non-clinical research).

This landscape of health research happens most frequently in basic science and data, long before many of the studies that we as patients encounter in clinics. These studies are carried out on the laboratory benches, though microscopes and computer models. You can read more here.

Involvement, engagement, participation.

Engaging the public has for a long time been part of non-clinical landscape with excellent and informative open days, lectures and practical workshops but too often it is a one-way street. The potential to create a dialogue with the public exists and is developing rather than the public receiving knowledge.

Science takes years with many setbacks yet recently we have seen an increase in new medicines being developed and tested in phase 1 studies – sometimes called ‘first into human’ or ‘bench to bedside’. Many of these have dramatically improved the outcomes for patients. 

There has also been greater interest from patients and the public in meeting and working with researchers in this field to share insights, experiences – a keenness to be more than just informed about a discovery and to be partners in a more joint endeavour.

The terms of ‘involvement’, ‘engagement’ and ‘participation’ are often used to describe and define such activities but do these get in the way? Might these do more to protect professional boundaries rather than necessarily meeting the needs of the public and research? I do accept some personal blame for this as I argued for the patient voice to be heard through the term patient, public involvement.

It should surely not be a matter of joining an advisory group or become a member of a steering committee to have a say; to sit through a presentation to find what is needed; or take part in a health study to learn more about health research. 

The shift to research being conducted with people rather than to them has grown in clinical research and is increasingly becoming the culture and practice within discovery research. It is sometimes called co-production and defined by principles of partnership. It doesn’t mean that everyone is doing everything together. The recent UKRI Medical Research Council review by the Vocal team, of which I was a member, clearly demonstrates the interest and variety of public partnerships that are taking place. You can read more about the review here.

The questions we may wish to ask.

As we consider about what a sound partnership with the public might look like, might we want to want to ask ourselves which questions bring us together:

– How can we help people (researchers, the public and patients) to better navigate their way through the landscape of non-clinical research to find what they need?

– How can we ensure that the information is in appropriate formats and plain language that can be more easily understood? 

– How can ensure that those whose health may be affected by the areas being researched are equal partners in discussions?

– How can we all tackle health inequalities and ensure that research is authentically inclusive?

– How can we maintain trust through transparency and collaborative partnerships with the public and non-clinical research?

– How might we gather and record examples of how these partnerships have helped improve research?

Central to any meaningful public partnership must be an explicit focus on Equality, Diversity and Inclusion alongside the principles of mutual respect, benefit and learning. Whatever we are doing together should not make things worse for any group or community. It must about open enquiry.

Co-design and production in this context are about the concepts of meeting together to benefit from each other’s understanding, insight and knowledge; to enhance how the research might be appropriate, relevant and applied to improving health. It is not the public necessarily ‘doing’ the actual science though laboratory visits or video tours can help build the relationship. It is about two-way conversations, a dialogue with purpose of improving the processes, conduct and outcomes of this research. 

Why public partnerships are important.

It may be worth remembering the reasons that we need to create, build and maintain such partnerships with the public.

For research, the opportunity is to gain from the public’s opinion, understanding their concerns and learning from their experiences. This provides additional information for scientific knowledge. Such partnerships go towards the integrity of high-quality research and help maintain trust. It also has the potential to inform and enrich the way research is communicated.

For the public, these partnerships offer opportunities to gain knowledge about current scientific thinking and the complexity of the work that is taking place. This helps provide realistic information and understanding.

As the science gets more complicated and complex it risks being further away from public accessibility and understanding so it is vital to build those bridges and make those links between the laboratory bench, patient experiences and meaning for the public. As data gets collected and mined it is possible to diagnose earlier, treat faster and potentially have better outcomes it is necessary to address concerns around how it is used and Artificial Intelligence. As digital technology provides answers at our fingertips 24/7, knowledge is no longer owned by a few.

What matters in partnership.

What does matter is that in all discussions with researchers that we are clear about why we are meeting, the intention and what might result. It is about being deliberate and specific in our expectations.

It is about keeping people informed in a genuinely collaborative, open and enquiring approach; agreeing how you will record what you have learned together.

For me, it is about how can I find the information I need to maintain the best personal health; understand the latest research findings; use my experience and insight to help further that research; and/or being able to know about research that is taking place in a transparent manner.

Engaging and actively involving the public with non-clinical research

I have the great pleasure of working with the Vocal team, based in Manchester who are excellent at “bringing people and health research together”. This post is also informed by my work with the Health Research Board – Trials Methodology Network, (HRB TMRN) Ireland.

The Vocal team recently carried out a Public Involvement Landscape Review with the Medical Research Council (MRC) a part of the United Kingdom Research & Innovation (UKRI). The main report clearly shows that patients and the public are actively involved with the the non-clinical landscapes of laboratory work, discovery science, digital and methodological research.

But, why are we engaging and involving the public and what might be the benefit for the research, the members of the public and the research teams?

The table below attempts to identify certain key purposes (in bold) in the middle column along with a brief outline of what that might mean for the actual research. The columns either side offer some examples of the benefit to the individuals involved – public/patients on left and researchers on the right.

The benefit and value of engaging and involving the public will likely vary according to the purpose of meeting and the issues being discussed. If however, we are clear about how the research might benefit and what we might mutually gain then we we help make the purpose of meeting meaningful. This is especially important where there is no direct patient/public contact as in non-clinical landscape and patient experience is less of a requirement.

These purposes help lead us to the goals of inclusion, transparency and trust that need to reflect the diversity of our communities.

I would appreciate any thoughts, comments, changes or criticisms that help develop our understanding of the added benefit of working together.

This previous post on involving patients and the public with health research in labs, science, numbers and methods may be of interest

#FUTURETRIALS 

The University of Galway – Institute for Clinical Trials – Some reflections on the launch event

It starts here…with Kate describing the patient experience of a stage 4 cancer in a short film. We feel every moment from diagnosis, treatments through to an immunotherapy study and children having more time with their Mum. The voice of a patient as a powerful reminder of purpose and driver for change. 

It starts here… with a real in-person meeting in Galway that brings together all the parts in Ireland that hold sway in how research is done. I can’t think who wasn’t there. All the speakers mentioned the importance, the value and the need to involve the patients and the public (I remember when I felt I was intruding by even mentioning the patient).

It starts here…with a fundamental rethinking, reframing and resetting of the agenda. Speakers stressed the need for a collaborative and team approach – the academic, health professionals, industry and communities working together – striving to improve people’s lives. Speakers stressed the dramatic discoveries that are taking place in science, with data, technology and in the way we conduct research studies. It is what patients expect.

The it…is a new Institute for Clinical Research, led by Prof Peter Doran at the University of Galway. A partnership driven by excellence, focused on personalised care and which takes account of the complexity of people’s lives. Peter makes a plea for no more silos which most patients will welcome. 

It is as much about improving peoples health as changing the health research system. The doing better trials is part of how we get there. it is progressive, ambitious and exciting. It is set out in The Future Trials Strategy 2023-26  which underpins the initiative.

It is built on strong foundations the University of Galway Strategic Plan and the College of Medicine, Nursing and Health Sciences Strategic Plan 

These strategies and plans, amongst others, fit together like a glove. Well done Dr Martina Ní Chúlain, Martin O’Donnell among others. 

As the University President Cairán Ó hÓgartaigh quoting Simon Senak – It Starts with WHY.  In the case of the University of Galway that is simple for students, the community and public good. 

It is the latter that strengthens the importance of the University’s role as the lead partner for the PPI Ignite Network. The experience, the voice and presence of the patient and the public is increasingly playing a vital role in informing, influencing and shaping clinical research.

The exciting development, in recent years, is the increase in active involvement in the landscape of non/pre-clinical research. One of the speakers, Prof Bill Powderly reminded all of us that the “The fundamental process of discovery translation cannot be a bridge to nowhere.” Michael J Fox Parkinson’s Foundation – Future Cures 

Work in laboratories may still take years but the translation from ‘bench to bedside’ for patients is becoming more important and meaningful.  Phase 1 studies are  making significant differences to people’s lives so the role of the Institute for delivery in enabling people to speak to each other from each side of the bridge is vital.

There is therefore a growing need to strengthen the relationships and dialogue with the public to maintain trust and for greater transparency. There is mutual gain in engaging and involving the public to increase knowledge and understanding about basic science as much as providing those scientists with real world insights, opinions and perspectives especially with regard to the opportunities, the risks and the uncertainties.

I have recently been working alongside Vocal who are based in Manchester, UK on a review of Patient, Public Involvement (PPI) within the non-clinical landscape (laboratory science, discovery, methodologies) the UKRI Medical Research Council. You can read about the Looking Forward Review here.

The Institute sets out its strategic direction across 5 themes of developing, delivering, innovating, training and influencing. In addition to the Institute a second Institute for Medical Technologies and Advanced Therapeutics Discovery will be established.

These are exciting times and I look forward to hearing more about how patients and the public are informing, influencing and shaping #FutureTrials.

These voices along with the other speaker’s presentations remind us why this is so important. 

Read about the experience of the Health Research Board Trials Methodology Research Network‘s Schools START Competition here

Trials Research Methodology – FUN! Who knew????

My first tweet sent within the first half an hour…

“Brilliant, exhilarating, exuberant, fun, informative and…educational.”

I know!!! 

This image has an empty alt attribute; its file name is img_0477.jpeg

These are not the words that immediately spring to mind when we think about Trials Methodology Research. They are certainly not how other patient and public partners think. 

Bear with me as I explain…

This is about us understanding science, research methods in a super charged, respectful and joyous manner. We are in the Aras Moyola building at the University of Galway on Friday 19th May 2023. The event marks International Clinical Trials Day #ICTD23

I had read about the START competition in Irish primary schools but nothing prepares you for the sheer visceral nature of the experience of attending the celebratory event in person and being present in the moment. 

As each school enters through the front door they are applauded by a reception group of PhD students, researchers and university staff. This acknowledgment recognises the work the young people have put into their research. The faces reveal reactions that move seamlessly between surprise, pleasure and a slight embarrassment yet – all clearly appreciate the praise that is being offered. 

The day is about the young people as researchers and as participants.

You might even swear you have just witnessed these youngsters grow in height, self-belief and confidence. 

The schools move into the Lecture Theatre. I imagine this to be for a formal university style welcome. Oh dear, wrong again! 

One of the team is the DJ inviting pupils to choose songs and so we have singalongs, karaoke, dancing, shout outs for certain songs. When has trials methodology been so good? 

This comes to an end when all the schools have arrived and are seated. Is this the formal welcome?  Well… No! 

The pupils are invited, in small groups to meet their ‘guides’ (PhD students from different Universities across Ireland who volunteer) for the day and are led off to any one of a number of highly interactive experiments, activities, meeting and stroking animals. This is all about the young people. It is their day. 

Lunch is a sit down affair for everyone and it is of such good quality. 

The afternoon was the announcement of the winner of the research project but not quite yet. 

Before the judges announced the winners we were amazed one more time by the University of Galway’s Kitchen Chemistry team with fun yet thoroughly interesting experiments. 

We were all enthralled to hear from Shane O’Conner and Liam Carew, the winners of the BT Young Scientists of 2023 winners. It was inspiring to hear of their research and their perseverance to get there.

The START Competition is all about schools being invited to think of questions relating to their health they would like answered, reaching an agreement about which is their priority and then continuing to use a randomised trial methodology to study that question.

The top 3 trials planned, led

& reported by children this year were from:

Currow National SchoolRanalough, Killarney in County Kerry who had a debate about running and wanted to gather evidence to answer – “Should you run for distance or time?”  

Scoil Mobhi, from Glasnevin in Dublin 9 were keen to know – “Which method of learning produces better results in a test: educational videos or educational books?”

Corrandulla NS, Corrandulla, Galway wanted to find out – “Do mindful opportunities increase concentration?”

The judges, Shaun Treweek, Sarah Chapman, Iseult Mangan, Aisling Murray had reflected on why certain questions were asked, chosen and the way that the schools chose to answer them, about the way the control and target groups were kept apart, the possibility of bias, the step-by-step process and the way the results were assessed and shared. 

All the aspects of good trial design, planning, conduct and dissemination. 

The Winners are Currow National SchoolRanalough, Killarney in County Kerry

This was in a couple of words Research Jubilation – the joyful expression of people coming together to celebrate a common interest – schools, pupils, students, staff. Happiness and a triumph of collaborative thinking and doing. Research Methodology made fun – who would have thought it – well actually it is thanks to all those at the Health Research Board – Trials Methodology Research Network (HRB-TMRN) with whom I am privileged to work and call friends.

As Richard P Feynman says “What did you ask at school, today?

I learned to hold and speak with an owl.

Trial Methodology – through a photographic lens

Written on behalf of the Health Research Board – Trial Methodology Research Network, Ireland (HRB TMRN)* in support of the Medical Research Council + National Institute for Health Research Trials Methodology Research Partnership (MRC-NIHR TMRP).

Trials Methodology Research, what does it do and 

why is Patient, Public Involvement important?

Over the past few years, I have become increasingly involved with Trials Methodology Research. 

As a result, I am more certain than ever that the experiences, voices and insights of the public and patients are both necessary and essential with this type of research activity. To achieve this dialogue we need to be present at meetings, in discussions, attend conferences and see the activity mentioned in publications. Involvement with trial methodologists has the great potential to inform, influence and shape the way that the actual research methods are made better for patient care.

This relationship can bring about improvements in the actual studies by making trials more efficient, improving the experience of taking part and delivering research as well as speedier results. It is this form of transformational change to the research processes that is in all our interest. Ensuring that the modernisation of the methods are needed, relevant and acceptable becomes a key function of the public and patient involvement. 

However, despite trial methodology sounding a bit daunting, a bit out of our ken, a little bit academic – my experience has been almost entirely positive, informative and enjoyable. These methodologists or triallists as they are often called are a welcoming bunch. For the most part they seem comfortable in knowing and accepting what they don’t know. Although we enter the discussion through different doors we find that we are often in the same place of wanting to find some answers.

It then becomes about what we all don’t know about issues such as recruitment, retention, rapid reviews, statistics, outcomes, adaptive studies, etc. It is about applying this common lens of working together whilst accepting our different starting points that helps each other understand the picture in front of us.

I may jokingly say, at times ‘my head hurts’ but that is mainly because of the detail of discussion, the precision of language but given time, I get there. The shift is that, it is not about me ‘the patient’ – it could be about any patients or not even patients. It is not necessarily about ‘taking part in a study’. It is about the methods of research being used. We are standing apart and looking at a bigger picture. But it is an interesting panorama.

How do I approach being involved with those in Trial Methodology?

I think that I can best describe this relationship, as opposed to working with clinical researchers through the metaphor of photography. Trial methodology looks through a quite specific form of lens and from a different angle.

As a former teacher using drama for learning, I would often begin by thinking about who the people in the story are most like – the phrase used in drama is ‘in the company of others’. It is a means of considering the roles that the pupils might take on and with whom they could be connnected. 

If I was inviting young people to journey to the New World in a sailing ship then they would be in the company of explorers, travellers, adventurers. It would help me think of objects we might use – baggage, letters home, diaries and maps. These is turn would symbolically help to build belief.

It would also help identify the other people: those who have to carry the equipment, the botanists who might go along; the sailors tasked with getting them there – each providing different perspectives, possible starting points for different lessons as a means of looking at things from different angles. It would help me think of the questions they might have, the phrases I might use to deepen the experience and the consider settings to add tension – the unknown, the dangers, the opportunities.

When we look for these parallels and divergences, we can better understand what they do and consider some of their challenges, to gather other viewpoints, gain insights into how they might have felt and developed a more thorough understanding of their experiences.

As we move from our personal experience of ill health we hear from other patients and carers – this leads to us asking more informed questions.

Research as Photography

In this same way, we might think of RESEARCHERS as being ‘in the company of photographers’ (taking a number of images or snapshots of people taking part in the same experience at particular moments in time). This can be helpful for us as patients and members of public. It places research in a more understandable context. It helps us think of their world in a familiar way (Almost everyone has taken a photo at some point). 

Photographers want the best and most appropriate images (some with the latest cameras and others with what is available). 

Methodologists as Research Technicians

With this in mind, it is possible to view Trials Methodologists as being ‘in the company of those improving the process of photography’ (modernising the camera, improving the lens and shutter speeds, looking at how to take better pictures, thinking about lighting and tints, making photography available for more people). 

Trial Methodologists are the specialists, the technicians, the artisans, the experts in specific areas. They are changing and transforming the way we plan and do studies, collect the evidence, determine outcomes and think about how to transform the method.

Evidenced Based Research Methods

Trial Methodology Research is therefore about gathering the evidence that shows that these changes are worthwhile. It is about trials and other well-designed studies that set out to ask the most relevant and appropriate questions that will help transform the research methods that might lead to better health.

It was a patient, who became a statistician, that questioned the way many doctors carried out their research and is seen as an elder of the modern randomised controlled trial for healthcare. Austin Bradford Hill wanted to study medicine but a period of tuberculosis meant that he took up economics and became involved with statistics instead. He established many of the statistical aspects of trials that we see today to ensure sufficient numbers, control groups etc. 

Perhaps, this is one of the first examples of patient involvement. However, we don’t necessarily need to have been a patient though it can provide a useful experience to drive change. It is fundamentally about bringing a fresh pair of eyes yet a patient experience perhaps brings the particular sharpness to the focus.

The Finer Details

As the methodologists delve in complex fine detail, our other key role as patient/public, becomes about finding ways of translating this into clear language, pictures and diagrams. 

This is, for the most part, not about our illness or any treatment. It is our understanding as a patient or member of the public that we bring to the table (i.e. we didn’t enter through the door marked ‘Research Career This Way’).

It is the insights we have gained about health and social care settings. It is our knowledge of how to find, approach and involve people in research as active partners and participants in a study. It is those other life experiences that guide our observations, advice and comments. These become the more refined understanding and wisdom brought by many experienced patient advocates. 

Involvement with research methodologists is in many respects similar to the involvement with a laboratory-based researcher. We don’t need (or necessarily want) to understand the detail of the how they are going to alter cell mutation, know about the complex processes they will use and how it might eventually be turned into a treatment for a specific disease. It is again about the big picture, making connections and the fine detail gained from our knowledge.

The lab-based researcher finds it motivating to meet people affected by the condition they are studying; They find it useful to consider whether the medicine might be best tested in primary or secondary care. They see the need to explain their work in ways that is understandable. 

It is always worth remembering that many of those who will review research proposals to decide whether it should be funded are not themselves specialists in the specifics of research methodologies. 

Our role, as patients and the public, is to ask these researchers to explain why this might be valuable and what difference it might make. The opportunity is that we learn more about these fine details and develop more precise questions.

From a single photo, through family albums to social media

My family have a single photograph, we believe, of my great, great grandfather. It is small and printed on a metal plate taken sometime in the the 19th Century. We have collections in albums of homes, house and occasions.

Today, we all have probably thousands of photographs of the family, available on phones, posted on social media, sent as attachments, edited and altered using easily accessible apps. It is a more universal, open and accessible, as is research.

And yet

I still have no real understanding of how a smartphone camera actually works and nor do I really want to. Similarly, I don’t understand the detail in trial methodology. I do, however, know how to take pictures, edit them, post them and the technicians need that information, those insights and learn.

So, how do we encourage other patients and members of the public to become actively involved in aspects of health and care research methods to improve outcomes? Equally how do we encourage trial methodologists to open the doors to our involvement?

Before, beside and beyond – (part 2)

This post is based on a Workshop Presentation for the Health Research Charities Ireland (HRCI) – Shared Learning Group on 23rd February 2022. Please look out for the Tweetchat on 9th March 1900-200hrs (GMT). The before, beside and beyond refers to that health research that happens in labs, through molecular microscopes, on computers with pre or non-clinical studies.

Patient, public involvement (PPI) with this landscapes requires a little more thought and preparation. Many aspects are familiar yet others present some challenges

Some SIMILARITIES and CHALLENGES for involving patients and/or the public

Patient, public involvement with pre/non-clinical research still means meeting researchers, taking part in discussions, reading papers, emails and commenting on proposals but it is less about our personal experience. It is like taking a side step.

Involvement is still about providing a public and/or patient perspective, offering opinions on relevance, advising on and suggesting clearer language and bringing a reality check. This then becomes more about helping people understand their role and comprehend how they can contribute.

The challenges, of course, are that it can be more complex, complicated and involving a very detailed nature of research so how do we help people join in? 

It may feel as if there is less to contribute so how might we giving confidence?

Greater time may be required to tune-in, absorb what is required of the involvement so what support should we offerThe longer timescale often means less frequent meetings so what can we do to keep-in-touch?

However, the opportunity to learn about research is immense. Through my own involvement in meetings such as these, I ask better questions.

SETTING the SCENE, the TASK and the ASK

It appears that we might like to consider that it is the context, content and conduct of non-clinical research that separates it from involvement with clinical research.

Setting the Scene (context) – the settings and surroundings of non-clinical research are often quite different from the familiar clinical settings of most people. The places and the work researchers do are often separate from the standard patient pathways. They may have little or no actual contact with patients.

Yet, the work being done and where it takes places can be aspects of curiosity. Harvey’s Gang began because a young boy asked what happened to the blood sample they took. 

These can be of great interest and revelation to the public whilst also appearing slightly foreboding. 

I was rather disappointed to discover that the heralded process of ‘study randomisation’ was in reality two people entering data on a computer. They were very pleasant and the computers were great but I was hoping for a lottery tumbler. 

It may be difficult with public involvement to actually visit the laboratory, the computer suites and/or the tissue banks. There may even be closed laboratories yet it is possible to take pictures or a short film clip. Meeting may take place in a University setting rather than the NHS.

Scientific researchers might like to consider looking out for any You Tube clips, animations or presentations by themselves or colleagues that might help explain what they do.

Public partners might like to consider can think of groups, online communities that might welcome a talk, a tour and presentation.

Describing the Task (content) – The research may be more scientific, going into the detail of medicine development or tissue sampling, so the content might be quite complicated. It is, however, important to remember that public involvement is not about fully knowing the science but to encourage greater relevance, clearer language and better understanding.

Non-clinical researchers might like to give thought to examples and metaphors. It is helpful to be clear about the purpose – grounding in reality – a series of chats and conversations about your work.

Public partners might consider examples from their life experiences that explain the science. They may make useful suggestions to the language in lay summaries and other information about the research.

What is the Ask? (conduct) – This is about the actual what, when, where and how the involvement gets done. 

It needs some basic information about the study which is not just the protocolThe way we may be more spread out, have numerous failures, take time; quite specific and less formal meetings; worse things happened on the floor of the steel works in Sheffield – Karen Wilman

It may just start with a simple conversation, with a catch up in three months time, with an email update (even when little or nothing has developed). 

The catch up can be a chance to think about what you have learned from meeting each other and whether or how you have used that knowledge. It might even just be about how you have managed during Covid. 

Put a note in your diaries for a time ahead to contact each other for a further catch up; add reminders on certain dates – annual get together on date submission of funding application, etc.

Question for Workshop: Think about these in terms of a Rough Guide to a City or Country. What might you need to include in yours?

PEOPLE AND PLACES TO SEE

I have chowen a few examples that illustrate a range of involvement happening before, beside and beyond patient experience.

Dr Emma Dorris, emphasises the contribution involvement makes to Quality & Clarity, Needs and Value

https://sciencetrends.com/bridging-the-gap-between-research-and-impact-public-and-patient-involvement-in-health-research/

Parkinson’s UK, Alzheimer’s Society and University College London Biomedical Research Centre have produced ‘A Practical Guide to Patient and Public Involvement in lab-based research’ – mentions that involvement provides reassurance and motivation to continue, help to think differently and to raise new questions

https://sites.google.com/parkinsons.org.uk/ppi-in-lab-based-research

Bella Starling and Jemma Tanswell look at social change and innovative ways re-imaginging the positive assets that diverse young people bring to science and health research

https://researchinvolvement.biomedcentral.com/articles/10.1186/s40900-018-0122-2

Consumer buddies in Australia provide insight into how their research can make a difference in the community

https://www.wehi.edu.au/research-research-fields/clinical-translation/consumers-and-research

Alice Biggane, et al talks about Involvement being key to research Integrity, Value and Quality in her paper about Methodological Research

Lynn Laidlaw, Irene Soulsby, Bea Goulão and myself – Figuring it Out blog post talks about involvement grounding statistical research in reality, helping it to make sense and motivating the work

Luca Marciani Involving children and young people in research from inception of a novel medical device to a multi -centre trial – showed the development of a mutually beneficial partnership, enabling genuine knowledge exchange

What might public good look like for the best research?

As we read through these papers and others, it is possible to identify certain themes that are inherent in why we need to involve patients and the public in this research landscape. Here are some themes that I have noticed…

  • Integrity & Trust – for high quality scientific research 
  • Quality & Clarity – in the language and communication of proposals 
  • Needs & Value – in terms of relevance and appropriateness of the research 
  • Grounding research – in reality and patient experience
  • Affirmation & Reassurance – that it is the ‘right’ thing to be doing
  • Encouragement & Motivation – for researchers to carry on
  • Learning & Development – about research for public partners
  • Different thinking – fresh ideas and new questions

WHERE MIGHT YOU BEGIN

Some suggestions for researchers

  • Perhaps start with a couple of people who are curious, interested and willing to help
  • Seek out some others who might like to get involved and invite them to meet for a chat about your area of research
  • Reflect on learning and look at ways of communicating with wider networks
  • Identify specific things that might/would benefit from patient experience, the patient/public voice and their presence 
  • Ask yourselves what you might do next and how you be even more open, to engage and involve the public

The Challenge is to find ways of bringing more people in whilst extending the breadth and depth of the discussions. The danger is a few people assimilate and exclude others.

Before, beside and beyond (part 1)

When we look at involving people with all that non/pre-clinical, lab-based, biomedical, methodological research it is worth considering that this is simply the study of health that happens before, beside and beyond patient/carer experience.

So, what does Patient, Public Involvement look like with this research landscape?

Yet, it precisely because of patient/carer need and patient experience that it is funded so it is in our interest to be involved. It is a landscape where patient, public involvement is increasingly taking place and the workshop where I presented these thoughts helped drive these posts.

This post is based on a Workshop Presentation for the Health Research Charities Ireland (HRCI) – Shared Learning Group on 23rd February 2022. Please check out Twitter for the Tweetchat using hashtag #Involvement_Preclinical

 A Necessary Connect

Sir Paul Nurse – Director of The Francis Crick Institute

The connection between pre-clinical, lab-based research with patient need is of growing importance and value. It has become evident throughout the Covid-19 pandemic that this is a necessary connection that is also required across other health issues to help make greater meaning. 

Informing, engaging and actively involving patients and the public is a means of connection – making these bonds real, tangible and practically valuable for biomedical research. Active involvement, where genuine partnerships are created and developed, has the additional potential to increase understanding amongst patients and the public in science, engender trust in evidence and challenge fake news at a time of such rapid communication through digital technology. 

This is fundamentally about our science, our clinical care and the concept of public good being research that is relevant, meaningful and applicable for people in today’s world. It is learning about the developments and changes in science, data and IT. The more open and transparent research becomes the greater the potential for improving health.

It should be by necessity a joint endeavour and an opportunity for mutual learning. It should not just be about going through the motions of engagement and involvement. It is about having clarity of purpose and meaning to improve this research.

Patient and public involvement and engagement (PPIE) has the means of increasing and strengthening that connection with basic science as well as the reciprocal development of a greater understanding of biomedical research. It is in all our interests. 

POINTS OF VIEW

As I begin to unpick the features and benefits of patient and public involvement in pre-clinical and lab-based research, it is worth pausing to reflect upon the world of clinical research

Clinical Research is closely related to our health experiences. It allows us to find ways in which we, as patient advocates, might compare, contrast and use our personal encounters to assist the research teams. We draw upon our direct knowledge to understand, reflect and strengthen those connections spoken about by the Paul Nurse, the Nobel Prize winner. 

If we took pictures of Clinical Research on our smartphones…. it is likely to be a series of portrait photos showing the participant and research nurse interactions – explaining the study, asking questions about what is required, signing the consent form, taking part in the trial, sending and the participants receiving the results.

These portrait photos have an individual quality with a distinctive and particular style and form. There is a unique agreement and commitment. It is the willingness, the volunteering and the altruism of trial participation. It is for the most part the researchers involved with people in clinics and healthcare settings. It has a personal feel.

In comparison, the lab-based experience invites us to consider photography with a narrower focus and a broader more general appeal – we are altering both the lens and the perspective. It becomes more indirect and may feel initially less personal.

CHANGING LENS & PERSPECTIVE

The LENS of non-clinical research becomes adjusted to the close up – the microscopic or even molecular – (looking at human tissue, chemical formula, Petrie dishes). Or we are looking at research data in minute detail.

The PERSPECTIVE turns the camera around to landscape mode – to a wider panorama (lookinga disease, a condition or a population – (about chemistry, physics, bioengineering, etc). 

In terms of Covid it means looking at the complicated patient experiences alongside the complexity of the science and the elaborate development surrounding vaccines and medicines. It is bridging these connections that helps us all understand. 

You may like to consider whether this analogy of photography and cameras help us all to be clearer? Does it help to make a mental picture and connection to enable us, as patients and members of the public to navigate our way? Might it help lab- based researchers find a way of differentiating between their work and clinical researchers? If you don’t use photography as the metaphor, what else might you use?

Involvement with pre-clinical research is another step in learning rather than necessarily being some different type of involvement. 

Biomedical research is an interesting place to be for patients and the public as it develops our understanding of scientific research. Equally, our contributions can also help give purpose and reason for those working in this research.

So, what is actually different about involving patients and the public in the landscape of before, beside and beyond patient experience? Click here to read Part 2

You might also be interested in this updated post listing some of the examples of involvement in this landscape https://involveddotblog.wordpress.com/2022/01/18/involving-patients-and-public-with-health-research-in-labs-science-numbers-and-methods/(opens in a new tab)

An introductory blog post can also be found on the HRCI website: https://hrci.ie/guest-blog/

Involving patients and public with health research in labs, science, numbers and methods.

The research that regularly takes place before, beside and beyond patients and carers

#Involvement_Preclinical

Involving Patient, Families and Public in Pre-clinical or Non-clinical Research – Useful Sources of Information – originally posted Friday, 12 October 2018 and reposted in 2022

The idea of Patient and Public Involvement (PPI) in research is fairly clear when you meet, talk with and consult with patients. It can be perceived as more challenging when the research is done at a distance yet it is far from impossible.


Here are some articles, papers and websites that Bec Hanley and I found helpful in thinking about the issues around involving people in the laboratory, decontamination, animal and data research studies – ie pre-clinical or non-clinical research.


These were initially prepared for a Workshop with those working and affected by Creutzfeldt-Jacob Disease (CJD) hosted by the National Institute for Health Research – Central Commissioning Facility, Policy Research Programme,  (NIHR CCF PRP) in Twickenham. We are grateful for their support and to all those we interviewed and subsequently met on the day.


A number of the references were sourced through a Twitter request using #Involvement_Preclinical  so thanks to  @ERDorris @Katherine_JLA @_nratcliffe@bellastarling @gailfdavies @KristinaStaley2  @JulieEBayley and many others for retweets.

LATEST NEWS – Patient engagement in preclinical laboratory research: A scoping review – https://www.sciencedirect.com/science/article/pii/S2352396421002772 Many thanks to @StuartGNicholl1 for bringing this to attention after recent twitter posts.


The SOURCES are grouped into categories for ease of searching:

Patient and Public Involvement – Pre-clinical

Involving Patients in Pre-clinical Research This is a helpful article in the BMJ Open Science Blog by Katherine Cowan, an independent consultant and a Senior Adviser to the James Lind Alliance. 

Bridging The Gap Between Research And Impact: Public And Patient Involvement In Health Research Dr Emma Dorris makes the case for involving patients and the public as being about… Quality & Clarity, Needs and Value. 

Involving People in Laboratory Based Research This is a useful discussion paper from the Shared Learning Group on Involvement (Research) which brings together many of those working in engagement and involvement in the charity sector. It includes a list of papers about PPI in lab-based research. 


Facilitating Patient and Public Involvement in basic and preclinical health research. Paper by James Maccarthy, Suzanne Guerin, Anthony G Wilson, Emma Dorris


Involving Patients in Parkinson’s UK researchUPDATED GUIDANCEalong with other excellent resources and information from lab based researchers. Good You Tube video as well.

Diversifying audiences and producers of public involvement in scientific research: the AudioLab – Great example from Bella Starling and Jemma Tanswell about how we might reach out and merge engagement with involvement

Involving children and young people in research from inception of a novel medical device to a multi -centre trial – Luca Marciani and others.


Involving Children and Young People – Harvey’s Gang is a great example of helping young people to understand what happens elsewhere in a hospital eg with blood tests 

Autistica UK 
has developed a research strategy with the whole community
PPI Strategy for NIHR Health Protection Research Units – The Health Care Associated Infections (HCAI) and Antimicrobial Resistance (AMR) at Imperial have produced a Strategy for Involvement & Engagement


Involving People in Research – This Australian website has some good examples of involvement in health data – patient/family involvement is described here as ‘consumer’

For more general information, please go to NIHR Involve Briefing Notes for Researchers

Animal Research

Transparency and Public Involvement in Animal Research Paper on how patient involvement might increase openness 


The Animal Research Nexus This network provides information about understanding about animal research. They have recently produced anexcellent set of resources including You Tube clips

Patients in Research (in general)

Clarifying the roles of patients in research A BMJ Editorial on meaningful patient partnerships in research
Innovative Medicines Initiative -A guide to Involvement in EU funded research

Public Engagement 

Meet the Researchers – A simple yet effective means of making ‘engagement’ work for researchers and public Thanks @jonathanbooteThe public-engaged scientists: Motivations, enablers and barriersPaper by: Cerrato, SimonaDaelli, ValentinaPertot, HelenaPuccioni, Olga


Doing Public Dialogue The Research Councils UK worked with Involve who specialise in public engagement 
Patient Advocates In America, the CJD Foundation has created CJD Advocates
Sense About Science Public Engagement Guide that includes information on actively involving people
The 2 major supports in Public Engagement are National Coordinating Centre for Public Engagement – good source of information
The Wellcome Trust– produced a new strategy for engagement

Industry

Patient Engagement and Involvement in Research and DevelopmentAn article by Pfizer on the new opportunities for patient engagement
Improving Patient Involvement in the Drug Development Process Article on value of social media to engage patients 

Article in Pharma Phorumhttps://pharmaphorum.com/?p=53404
Engaging Patients In Clinical Trials With Alan Thomas & Juliet MoritzExcellent podcast about why the patient voice is important in trial development

Impact

Research Impact– Interesting and valuable resources from Dr Julie Bayley(https://juliebayley.blog)

Why Impact matters in User Involvement – Excellent resource from NPC

The National PPI Standards

Information about the PPI Standards 

….AND MORE  (I will continue to add and then categorise later)

From Canada @CAR_PSP via twitter on Involvement in Anesthesia Research

Count Me In – A great example of how patients can help with encouraging PARTICIPATION in a Study using a Vimeo clip Thanks @MBCNbuzz
Involvement in Evidence Synthesis – Wonderful example of how involving patients, families and public can make a difference in complex and complicated areas of research. Thanks @CochraneUK

Arthritis Research Conference in Ireland which included science, treatments and care with patients attending https://www.ucd.ie/conway/engagement/newsopinion/2018/togetherisbettertransformingarthritisresearchinireland/

Role Descriptions for Patient, Public Involvement

A Help or a Hinderance – Too Little, Too Much?

I recently received a ‘role description’ that might be helpful for a group I was invited to attend. The meetings were to take place every couple of months – each lasting an hour and a half. 

The ‘role description’ being proposed, for the patient partner, was 6 pages in length!

I thought – Just how much do I need to know? I began to ask – Am I applying for employment? I felt that, if I were new to this, I might have been put off joining the meeting.

The purpose of this blog post is to question whether such role descriptions, outlines or person specifications or even terms of reference have now become over long and too much. Are they more limiting and excluding in nature? Would it make me want to get involved?

This trend to produce extensive outlines is worrying as these were initially intended to be short, helpful, constructive and to aid inclusion.

At the heart of this, are some fundamental questions that need to be asked: Is everyone else who is asked to attend the meeting presented with a role profile and agreeing to any terms of reference? If not – why not? Why is the patient/member of the public being singled out? Where is the basic equality – if we are being seen as so different that we need everything explained?

A Selection Process?

The danger, for me, is that these outlines get used to identify and select people who match the descriptions as in most employment interviews. It suggests that I need to have these skills, knowledge and experiences. It risks people being chosen to fit in who likely to come a similar background, know about these things and similar to those already in attendance. 

It is our personal experience that matters. We are not there to fit in! We are there, to question, to focus the meeting on the purpose of improving patient care, a reminder to work together constructively. I like the quote – “Get into trouble – good trouble!” By the late US Senator John Lewis. I also use the phrase – it is good to disagree but unacceptable to be disagreeable.

When, with the Cancer Consumer Liaison Group, we began to put together such descriptions they were less than a page with accompanying opportunities of some further chats, explanations and workshops. The actual terms of reference for the group were just four simple but extremely well crafted lines. 

A Prompt for Conversation?

The role description was developed more as an aid for an initial telephone conversation and only sent out afterwards (we wanted to encourage people to join not put them off).

The intention and purpose was mainly about helping the individual consider what they were getting involved with, what we were trying to achieve, talk about what they might need and a little bit about the meeting. In essence, a bit of background and foreground. 

Our aim, in cancer, was to use our patient/carer experience to achieve more relevant and improved diagnosis, treatment and care. It was never really about patient and public involvement per se. 

It has always been about making a difference more than policies and procedures. We viewed the venture through models of change – both cultural and behavioural.

Function, Support, Focus and Reflection 

I will state that role descriptions can be useful in many ways in helping to…

  • understand the role and make clear the purpose of the meeting (FUNCTION)
  • identify areas where we may want or need further information or advice (SUPPORT)
  • relate our health experiences to consideration of the meetings (FOCUS)
  • review as a means of understanding and asking better questions (REFLECTION)

These are all ‘helping to’ rather being than explicit and prescriptive demands and requirements. The lengthier descriptions and details may be useful aids for those supporting and enabling someone to take on the role. 

They are useful ‘tuning in’ activities – so that we understand our task and the reasons behind the meeting. 

Not So Long Ago

Role descriptions were developed by asking people what they might have liked to have known at the beginning of their involvement. There were never intended to be a handout about everything you needed to know. They should be about useful information, essentials that might be required, prompts for discussion.

You wouldn’t tell someone going to France that they have to learn all the words from the Larousse Dictionary before the visit. You wouldn’t expect them to know the history and geography of the country. We might, however, suggest taking a simple phrase book, saying Bonjour and changing their currency into Euros. 

Twenty odd years ago, if I had been presented with some of these recent role descriptions, I would have probably felt that I couldn’t contribute in any meaningful way. I would have run away and missed out on meeting so many interesting people and learning from health research.  

We have to remember that we bring knowledge from our direct personal experiences. The understanding we need and gain from our involvement is just more experiential learning where we find out things as we need them. It is neither didactic nor linear. It expands our understanding tans helps us ask even more insightful questions. 

Person First

Start with the person – ask them what they would like to know and how they would like to receive the information. Some will ask nothing, others a few questions and a few might say they want to read everything available. Some will want to talk through the information, some will like to be redirected to different sources, animations or YouTube clips. Some will want to sit and observe the meeting.

There will, of course, be certain essentials that must be covered.

This approach enables the individual the choice as to whether to get involved and make the decisions about what they might need to know.

As you explore the purpose of the meeting invite them to consider transferring skills from other experiences – times when they have helped bring people together to find solutions, reminded people about common goals; intervened when others have different opinions.  

And finally 

In terms of the theme of mutual learning, it is worth exploring and explaining what patients and the public might gain from learning about research, the research methods, the science, health services and/or about how we make a difference. 

In all of this, I am not suggesting that we don’t need role outlines and terms of reference, even if it just for us in patient & public involvement. I am asking that we think more carefully about using them with greater awareness of inclusion and supporting those whose voices are least heard.